IFT122 Activators

Direct activators of IFT122 interact directly with the protein and enhance its function. These include chemicals that can bind to IFT122 and alter its conformation or activity, as well as chemicals that can modify the protein's environment or interact with its binding partners. Examples of direct activators include forskolin, nifedipine, and BAY K 8644. Forskolin directly activates adenylate cyclase, leading to increased cAMP levels and activation of the PKA pathway, which has been shown to interact with IFT122. Nifedipine blocks L-type calcium channels, indirectly augmenting intracellular calcium levels, and activating IFT122. BAY K 8644 directly binds to calcium channels, increasing calcium levels and activating the protein.

Indirect activators of IFT122 do not directly interact with the protein but instead act on upstream signaling pathways or cellular processes that can influence IFT122 expression or activity. These include chemicals that can activate or inhibit signaling pathways, modulate protein stability or degradation, or alter cellular processes such as redox balance or inflammation. Examples of indirect activators include lithium chloride, sodium valproate, XAV939, NAC, curcumin, resveratrol, metformin, and rapamycin. Lithium chloride and sodium valproate both activate the WNT signaling pathway, which interacts with IFT122. XAV939 indirectly activates IFT122 by inhibiting the WNT signaling pathway and promoting ciliogenesis. NAC and curcumin activate IFT122 by reducing oxidative stress and promoting ciliogenesis. Resveratrol activates IFT122 by activating the SIRT1 pathway, which promotes ciliogenesis. Metformin activates IFT122 by activating the AMPK pathway, which promotes ciliogenesis. Rapamycin activates IFT122 by inhibiting the mTOR pathway, which promotes ciliogenesis.